CHM Price sensitive 23 Dec 2025, 9:53 AM

$8.4 M funding to drive CHM CDH17 and resignation of CMO

Chimeric Therapeutics Ltd

Sign in to open PDF

No summary is available for this announcement — sign in to read the PDF in full.

Sign in for more about this company, including guidance changes and other insights.
Sign in